Search

Home > The Rounds Table > Season Finale: Dabigatran Reversal and Digoxin Mortality
Podcast: The Rounds Table
Episode:

Season Finale: Dabigatran Reversal and Digoxin Mortality
Category: Science & Medicine
Duration: 00:25:13
Publish Date: 2015-07-03 10:52:47
Description:

Subscribe on iTunes

Fahad and Amol want you to recognize that:

1. Idarucizumab as an agent that specifically reverses the hemostatic effects of dabigatran. 

2. A post-hoc analysis of the ROCKET-AF study showed that digoxin is associated with increased mortality in patients with atrial fibrillation.

The papers

Idaracizumab for Dabigatran reversal.

Digoxin use and mortality in ROCKET-AF.

Good stuff

http://www.smacc.net.au/about-us/welcome/

http://emupdates.com/wp-content/uploads/2015/06/Strayer-Opioid-Misuse-SMACC-Slideset.pdf

Screening for occult cancer in unprovoked Venous Thromboembolism.

Perioperative bridging anticoagulation in Atrial Fibrillation

The post Season Finale: Dabigatran Reversal and Digoxin Mortality appeared first on Healthy Debate.
Total Play: 0